Kalbe Farma Tbk PT (KLBF) - Net Assets

Latest as of June 2025: Rp24.19 Trillion IDR ≈ $1.42 Billion USD

Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has net assets worth Rp24.19 Trillion IDR (≈ $1.42 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp29.51 Trillion ≈ $1.73 Billion USD) and total liabilities (Rp5.32 Trillion ≈ $311.65 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are Kalbe Farma Tbk PT's assets to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp24.19 Trillion
% of Total Assets	81.98%
Annual Growth Rate	20.06%
5-Year Change	34.55%
10-Year Change	124.81%
Growth Volatility	23.42

Kalbe Farma Tbk PT - Net Assets Trend (2000–2024)

This chart illustrates how Kalbe Farma Tbk PT's net assets have evolved over time, based on quarterly financial data. Also explore KLBF total asset value for the complete picture of this company's asset base.

Annual Net Assets for Kalbe Farma Tbk PT (2000–2024)

The table below shows the annual net assets of Kalbe Farma Tbk PT from 2000 to 2024. For live valuation and market cap data, see Kalbe Farma Tbk PT market capitalisation.

Year	Net Assets	Change
2024-12-31	Rp24.59 Trillion ≈ $1.44 Billion	+6.36%
2023-12-31	Rp23.12 Trillion ≈ $1.35 Billion	+4.63%
2022-12-31	Rp22.10 Trillion ≈ $1.29 Billion	+3.91%
2021-12-31	Rp21.27 Trillion ≈ $1.25 Billion	+16.36%
2020-12-31	Rp18.28 Trillion ≈ $1.07 Billion	+9.40%
2019-12-31	Rp16.71 Trillion ≈ $978.88 Million	+9.23%
2018-12-31	Rp15.29 Trillion ≈ $896.20 Million	+10.08%
2017-12-31	Rp13.89 Trillion ≈ $814.14 Million	+11.47%
2016-12-31	Rp12.46 Trillion ≈ $730.33 Million	+13.95%
2015-12-31	Rp10.94 Trillion ≈ $640.94 Million	+11.42%
2014-12-31	Rp9.82 Trillion ≈ $575.27 Million	+15.50%
2013-12-31	Rp8.50 Trillion ≈ $498.06 Million	+15.31%
2012-12-31	Rp7.37 Trillion ≈ $431.95 Million	+13.13%
2011-12-31	Rp6.52 Trillion ≈ $381.81 Million	+12.89%
2010-12-31	Rp5.77 Trillion ≈ $338.21 Million	+20.48%
2009-12-31	Rp4.79 Trillion ≈ $280.71 Million	+10.27%
2008-12-31	Rp4.34 Trillion ≈ $254.57 Million	+8.16%
2007-12-31	Rp4.02 Trillion ≈ $235.36 Million	+13.34%
2006-12-31	Rp3.54 Trillion ≈ $207.67 Million	+26.06%
2005-12-31	Rp2.81 Trillion ≈ $164.74 Million	+90.02%
2004-12-31	Rp1.48 Trillion ≈ $86.69 Million	+44.55%
2003-12-31	Rp1.02 Trillion ≈ $59.97 Million	+57.12%
2002-12-31	Rp651.41 Billion ≈ $38.17 Million	+88.28%
2001-12-31	Rp345.97 Billion ≈ $20.27 Million	+13.16%
2000-12-31	Rp305.74 Billion ≈ $17.91 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Kalbe Farma Tbk PT's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2294179129300000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	Rp22.94 Trillion	93.30%
Common Stock	Rp468.75 Billion	1.91%
Other Comprehensive Income	Rp869.79 Billion	3.54%
Other Components	Rp310.10 Billion	1.26%
Total Equity	Rp24.59 Trillion	100.00%

Kalbe Farma Tbk PT Competitors by Market Cap

The table below lists competitors of Kalbe Farma Tbk PT ranked by their market capitalization.

Company	Market Cap
Slide Insurance Holdings, Inc. Common Stock NASDAQ:SLDE	$2.30 Billion
Jiangsu Cnano Technology Co Ltd SHG:688116	$2.30 Billion
ZTE Corporation F:FZM	$2.30 Billion
Kayne Anderson MLP Investment Closed Fund NYSE:KYN	$2.30 Billion
The Andersons Inc NASDAQ:ANDE	$2.30 Billion
Krungthai Card Public Company Limited BK:KTC-R	$2.30 Billion
Mister Car Wash, Inc. Common Stock NASDAQ:MCW	$2.30 Billion
ARIS MNG.CORP. F:ZP1	$2.30 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Kalbe Farma Tbk PT's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 23,120,022,010,215 to 24,590,433,810,000, a change of 1,470,411,799,785 (6.4%).
Net income of 3,240,636,626,000 contributed positively to equity growth.
Dividend payments of 1,433,930,309,000 reduced retained earnings.
Share repurchases of 460,484,944,000 reduced equity.
New share issuances of 3,088,500,000 increased equity.
Other comprehensive income increased equity by 44,347,595,044.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Rp3.24 Trillion	+13.18%
Dividends Paid	Rp1.43 Trillion	-5.83%
Share Repurchases	Rp460.48 Billion	-1.87%
Share Issuances	Rp3.09 Billion	+0.01%
Other Comprehensive Income	Rp44.35 Billion	+0.18%
Other Changes	Rp76.75 Billion	+0.31%
Total Change	Rp-	6.36%

Book Value vs Market Value Analysis

This analysis compares Kalbe Farma Tbk PT's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.62x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 15.62x to 1.62x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-12-31	Rp55.36	Rp865.00	x
2006-12-31	Rp69.79	Rp865.00	x
2007-12-31	Rp79.62	Rp865.00	x
2008-12-31	Rp89.07	Rp865.00	x
2009-12-31	Rp100.04	Rp865.00	x
2010-12-31	Rp123.14	Rp865.00	x
2011-12-31	Rp139.01	Rp865.00	x
2012-12-31	Rp157.26	Rp865.00	x
2013-12-31	Rp181.33	Rp865.00	x
2014-12-31	Rp209.44	Rp865.00	x
2015-12-31	Rp233.35	Rp865.00	x
2016-12-31	Rp265.89	Rp865.00	x
2017-12-31	Rp296.41	Rp865.00	x
2018-12-31	Rp326.28	Rp865.00	x
2019-12-31	Rp356.38	Rp865.00	x
2020-12-31	Rp389.90	Rp865.00	x
2021-12-31	Rp453.69	Rp865.00	x
2022-12-31	Rp475.05	Rp865.00	x
2023-12-31	Rp499.83	Rp865.00	x
2024-12-31	Rp532.41	Rp865.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Kalbe Farma Tbk PT utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 13.18%
The company shows good efficiency in utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 9.93%
• Asset Turnover: 1.11x
• Equity Multiplier: 1.20x
Recent ROE (13.18%) is below the historical average (20.18%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2001	9.44%	1.60%	1.09x	5.43x	Rp-1.93 Billion
2002	40.98%	10.42%	1.27x	3.09x	Rp201.79 Billion
2003	31.55%	11.18%	1.18x	2.39x	Rp220.54 Billion
2004	25.17%	10.91%	1.13x	2.04x	Rp224.39 Billion
2005	25.08%	12.01%	1.27x	1.65x	Rp423.89 Billion
2006	21.57%	12.59%	1.31x	1.30x	Rp409.95 Billion
2007	20.21%	11.59%	1.36x	1.28x	Rp409.98 Billion
2008	19.00%	10.48%	1.38x	1.31x	Rp391.05 Billion
2009	21.91%	11.55%	1.40x	1.35x	Rp570.60 Billion
2010	23.28%	13.14%	1.45x	1.22x	Rp766.61 Billion
2011	23.37%	13.96%	1.32x	1.27x	Rp871.36 Billion
2012	23.52%	12.72%	1.45x	1.28x	Rp996.76 Billion
2013	22.58%	12.00%	1.41x	1.33x	Rp1.07 Trillion
2014	21.03%	11.89%	1.40x	1.27x	Rp1.08 Trillion
2015	18.32%	11.20%	1.31x	1.25x	Rp910.41 Billion
2016	18.45%	11.87%	1.27x	1.22x	Rp1.05 Trillion
2017	17.30%	11.91%	1.21x	1.20x	Rp1.01 Trillion
2018	16.07%	11.66%	1.16x	1.19x	Rp927.67 Billion
2019	15.01%	11.08%	1.12x	1.21x	Rp836.21 Billion
2020	14.96%	11.83%	1.02x	1.23x	Rp905.65 Billion
2021	14.97%	12.12%	1.02x	1.21x	Rp1.06 Trillion
2022	15.31%	11.69%	1.06x	1.23x	Rp1.17 Trillion
2023	11.97%	9.09%	1.13x	1.17x	Rp454.75 Billion
2024	13.18%	9.93%	1.11x	1.20x	Rp781.59 Billion

Industry Comparison

This section compares Kalbe Farma Tbk PT's net assets metrics with peer companies in the Drug Manufacturers - General industry.

No peer company data available for comparison.

About Kalbe Farma Tbk PT

JK:KLBF Indonesia Drug Manufacturers - General

Market Cap

$2.30 Billion

Rp39.20 Trillion IDR

Market Cap Rank

#5765 Global

#52 in Indonesia

Share Price

Rp865.00

Change (1 day)

-1.14%

52-Week Range

Rp865.00 - Rp1600.00

All Time High

Rp2271.54